Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Neurologic Clinics|November 18, 2023
Multiple Sclerosis in Black and Hispanic Populations: Serving the UnderservedMitzi J Williams, Christopher Orlando, Jemima Akisanya, et al.Multiple Sclerosis and Related Disorders|January 14, 2024
Walking and physical performance in black and white adults with multiple sclerosis controlling for social determinants of healthTrinh L T Huynh, Mitzi J Williams, Robert W MotlMultiple Sclerosis and Related Disorders|July 24, 2023
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world dataLilyana Amezcua, Terrie Livingston, Brooke Hayward, et al.Multiple Sclerosis and Related Disorders|June 20, 2021
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studiesBruce A C Cree, Ashish Pradhan, Jinglan Pei, et al.Neurology. Clinical Practice|July 3, 2015
Multiple sclerosis in US minority populations: Clinical practice insightsOmar Khan, Mitzi J Williams, Lilyana Amezcua, et al.Current Medical Research and Opinion|September 1, 2017
Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetateMitzi J Williams, Kristen Johnson, Helen M Trenz, et al.Journal of Health Psychology|March 5, 2014
Variables associated with patient activation in persons with multiple sclerosisMarie-Christine R Goodworth, Lara Stepleman, Judith Hibbard, et al.Therapeutic Advances in Neurological Disorders|April 19, 2024
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosisLaura Airas, Robert A Bermel, Tanuja Chitnis, et al.Neurology|April 26, 2022
Advancing Care and Outcomes for African American Patients With Multiple SclerosisAnnette F Okai, Annette M Howard, Mitzi J Williams, et al.Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEMAngel Chinea, Lilyana Amezcua, Wendy Vargas, et al.Pageof 2